IP Library › Patent Application 12279898
Patent Application
App. No. 12/279,898

SALT OF CD 80 ANTAGONIST

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/279,898
Abstract

The choline salt of the CD80 antagonist compound 4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-N-(2,2-difluoro-ethyl)-benzamide (I) has good aqueous solubility and is therefore convenient for pharmaceutical use.

Claims (4)

1 . The choline salt of 4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-N-(2,2-difluoro-ethyl)-benzamide of formula (A):

2 . An orally administrable pharmaceutical composition containing the choline salt claimed in claim 1 and at least one pharmaceutically acceptable carrier.

3 . An injectable aqueous solution of the said choline salt claimed in claim 1 .

4 . A topically applicable aqueous based liquid or cream composition containing the choline salt claimed in claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2011
From: MEDIGENE LIMITED
To: MEDIGENE AG
Reel/Frame 025938/0048 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2009
From: MATTHEWS, IAN RICHARD
To: MEDIGENE LIMITED
Reel/Frame 022349/0485 →